These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15993279)

  • 1. Delay in diagnosis and its effect on outcome in head and neck cancer.
    McGurk M; Chan C; Jones J; O'regan E; Sherriff M
    Br J Oral Maxillofac Surg; 2005 Aug; 43(4):281-4. PubMed ID: 15993279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and tumour factors associated with advanced carcinomas of the head and neck.
    Tromp DM; Brouha XD; Hordijk GJ; Winnubst JA; de Leeuw RJ
    Oral Oncol; 2005 Mar; 41(3):313-9. PubMed ID: 15743694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma.
    Scott SE; Grunfeld EA; McGurk M
    Oral Oncol; 2005 Apr; 41(4):396-403. PubMed ID: 15792612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with delay in the diagnosis of oral cancer.
    Pitiphat W; Diehl SR; Laskaris G; Cartsos V; Douglass CW; Zavras AI
    J Dent Res; 2002 Mar; 81(3):192-7. PubMed ID: 11876274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient factors associated with delay in primary care among patients with head and neck carcinoma: a case-series analysis.
    Tromp DM; Brouha XD; Hordijk GJ; Winnubst JA; de Leeuw JR
    Fam Pract; 2005 Oct; 22(5):554-9. PubMed ID: 16006495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects in oral, pharyngeal and laryngeal carcinoma--results of an overall Swiss cohort study].
    Wolfensberger M; Schmid S; Schatzmann E
    Schweiz Med Wochenschr; 1994 Apr; 124(16):678-83. PubMed ID: 8184303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative importance of diagnostic delays in different head and neck cancers.
    Teppo H; Alho OP
    Clin Otolaryngol; 2008 Aug; 33(4):325-30. PubMed ID: 18983341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of deprivation as a factor in the delays in presentation, diagnosis and treatment in patients with oral and oropharyngeal squamous cell carcinoma.
    Rogers SN; Pabla R; McSorley A; Lowe D; Brown JS; Vaughan ED
    Oral Oncol; 2007 Aug; 43(7):648-55. PubMed ID: 17070094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic delay of oral squamous cell carcinoma in two diagnosis centers in Córdoba Argentina.
    Morelatto RA; Herrera MC; Fernández EN; Corball AG; López de Blanc SA
    J Oral Pathol Med; 2007 Aug; 36(7):405-8. PubMed ID: 17617833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presenting symptoms of head and neck cancer.
    Robertson MS; Hornibrook J
    N Z Med J; 1982 May; 95(708):337-41. PubMed ID: 6954395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and pharyngeal cancer: analysis of patient delay at different tumor stages.
    Brouha XD; Tromp DM; Hordijk GJ; Winnubst JA; de Leeuw JR
    Head Neck; 2005 Nov; 27(11):939-45. PubMed ID: 16206281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
    Santos AB; Cernea CR; Inoue M; Ferraz AR
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
    González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic delays in laryngeal carcinoma: professional diagnostic delay is a strong independent predictor of survival.
    Teppo H; Koivunen P; Hyrynkangas K; Alho OP
    Head Neck; 2003 May; 25(5):389-94. PubMed ID: 12692876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
    Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
    Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cases of head and neck carcinoma detected by sputum cytology--lung cancer screening and head and neck cancer].
    Saito H; Ono I; Ebihara S; Yoshizumi T; Ikeda S; Ono R
    Gan No Rinsho; 1985 Oct; 31(13):1665-8. PubMed ID: 4079057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.